Skip to main content

Human CD99 Antibody

R&D Systems, part of Bio-Techne | Catalog # AF3968

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
AF3968
AF3968-SP

Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human

Applications

Validated:

CyTOF-ready, Flow Cytometry, Immunocytochemistry, Simple Western, Western Blot

Cited:

Flow Cytometry, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant human CD99
Asp23-Asp122
Accession # P14209

Specificity

Detects human CD99 in direct ELISAs and Western blots. In direct ELISAs, less than 5% cross‑reactivity with recombinant mouse CD99 is observed.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Scientific Data Images for Human CD99 Antibody

Detection of Human CD99 antibody by Western Blot.

Detection of Human CD99 by Western Blot.

Western blot shows lysates of NCI-H460 human large cell lung carcinoma cell line, U251-MG human malignant glioblastoma cell line, amd SK-Mel-28 human malignant melanoma cell line. PVDF membrane was probed with 0.25 µg/mL of Goat Anti-Human CD99 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3968) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF017). A specific band was detected for CD99 at approximately 32 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Detection of CD99 antibody in Human CD3+Lymphocytes antibody by Flow Cytometry.

Detection of CD99 in Human CD3+Lymphocytes by Flow Cytometry.

Human whole blood CD3+lymphocytes were stained with Goat Anti-Human CD99 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3968, filled histogram) or control antibody (Catalog # AB-108-C, open histogram), followed by Phycoerythrin-conjugated Anti-Goat IgG Secondary Antibody (Catalog # F0107).
CD99 antibody in HepG2 Human Cell Line by Immunocytochemistry (ICC).

CD99 in HepG2 Human Cell Line.

CD99 was detected in immersion fixed HepG2 human hepatocellular carcinoma cell line using Goat Anti-Human CD99 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3968) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). Specific staining was localized to cell membranes. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.

Applications for Human CD99 Antibody

Application
Recommended Usage

CyTOF-ready

Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.

Flow Cytometry

0.25 µg/106 cells
Sample: Human whole blood CD3+ lymphocytes

Immunocytochemistry

5-15 µg/mL
Sample: Immersion fixed HepG2 human hepatocellular carcinoma cell line

Simple Western

20 µg/mL
Sample: MOLT‑4 human acute lymphoblastic leukemia cell line

Western Blot

0.25 µg/mL
Sample: NCI‑H460 human large cell lung carcinoma cell line, U251-MG human malignant glioblastoma cell line, amd SK‑Mel‑28 human malignant melanoma cell line

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CD99

CD99 (also named MIC2, E2 and thymic leukemia antigen) is the founding member of the CD99 family of molecules. The CD99 family contains four members; CD99, CD99L2, XG and the pseudogene CD99L1 (1, 2, 3). Native human CD99 is 32 kDa in size and exists as a type I transmembrane glycoprotein. This is referred to as the long, or type I isoform. It is synthesized as a 185 amino acid (aa) precursor that contains a 22 aa signal sequence, a 100 aa extracellular domain (ECD), a 25 aa transmembrane segment, and a 38 aa cytoplasmic region (4). The ECD contains no identifiable motifs, N‑linked glycosylation sites, or cysteine residues; it does possess sites for O-linked glycosylation. The cytoplasmic region, albeit short, does have signal transduction capability (5). There are apparently multiple isoforms for human CD99. One shows a 16 aa deletion in the ECD (aa 34‑49), a second shows a 38 aa deletion in the cytoplasmic region (aa 122‑159), and a third exhibits a three aa truncation at the C-terminus (6, 7, 8). The best studied isoform shows an Asp‑Gly substitution for the C‑terminal 27 amino acids. This is referred to as the 28 kDa type II isoform (9). The type I and II isoforms have distinctive signal transduction pathways (FAK-src for type I; PI3K plus src-ERK1/2 for type II), and mediate clearly different biological outcomes (5, 9, 10). The two numbered isoforms may or may not co‑exist on the same cells. Peripheral T cells have only the long isoform, while double-positive thymocytes express both isotypes. What is unclear is the monomeric vs. dimeric status of CD99. In mouse, CD99 reportedly forms disulfide-linked homodimers (11). In human, however, CD99 is reportedly monomeric if only a type I isoform, and a covalent heterodimer if co‑expressing type I and II isoforms (12, 13). Cells known to express CD99 include fibroblasts, neutrophils, T cells, double-positive thymocytes, CD34+ stem cells, monocytes and endothelial cells (2, 12, 14, 15). Homophilic interaction between CD99 on the neutrophil and CD99 on the endothelial cell regulates the transendothelial migration of neutrophils during inflammation (16). Human CD99 is only 48% aa identical to mouse CD99 (17).

References

  1. Wilson, M.D. et al. (2006) Physiol Genomics 27:201. 
  2. Petri, B. and M.G. Bixel (2006) FEBS J. 273:4399. 
  3. Suh, Y.H. et al. (2003) Gene 307:63. 
  4. Gelin, C. et al. (1989) EMBO J. 8:3253. 
  5. Byun, H-J. et al. (2006) J. Biol. Chem. 281:34833. 
  6. GenBank Accession # EAW98698. 
  7. GenBank Accession # EAW98699. 
  8. GenBank Accession # EAW98700. 
  9. Hahn, H-J. et al. (1997) J. Immunol. 159:2250.
  10. Scotlandi, K. et al. (2007) Oncogene Apr 30; [Epub ahead of print].
  11. Park, S.H. et al. (2005) Gene 353:177.
  12. Schenkel, A.R. et al. (2002) Nat. Immunol. 3:143.
  13. Alberti, I. et al. (2002) FASEB J. 16:1946.
  14. Imbert, A-M. et al. (2006) Blood 108:2578.
  15. Dworzak, M.N. et al. (1994) Blood 83:415.
  16. Lou, O. et al. (2007) J. Immunol. 178:1136
  17. Shiratori, I. et al. (2004) J. Exp. Med. 199:525.

Alternate Names

CD99, MIC2, pilr-1, PILR-L

Entrez Gene IDs

4267 (Human); 673094 (Mouse); 652929 (Rat)

Gene Symbol

CD99

UniProt

Additional CD99 Products

Product Documents for Human CD99 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human CD99 Antibody

For research use only

Loading...
Loading...
Loading...
Loading...
Loading...